Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.
Compston JE, Audran M, Avouac B, Bouvenot G, Devogelaer J, Eastell R, Fabris F, Gennari C, Jones EA, Kaufman JM, Lemmel E, Mazzuoli G, Reid DM, Ringe JD, Vanhaelst L, Ziegler R, Reginster JY. Compston JE, et al. Among authors: devogelaer j. Calcif Tissue Int. 1996 Nov;59(5):323-7. doi: 10.1007/s002239900134. Calcif Tissue Int. 1996. PMID: 8849396 No abstract available.
Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in Science.
Reginster JY, Bruyere O, Audran M, Avouac B, Body JJ, Bouvenot G, Brandi ML, Gennari C, Kaufman JM, Lemmel EM, Vanhaelst L, Weryha G, Devogelaer JP. Reginster JY, et al. Among authors: devogelaer jp. Calcif Tissue Int. 2000 Sep;67(3):191-4. doi: 10.1007/s002230001135. Calcif Tissue Int. 2000. PMID: 10954771 Free article. Review. No abstract available.
Management of glucocorticoid-induced osteoporosis.
Rizzoli R, Adachi JD, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, Laslop A, Mitlak B, Papapoulos S, Ralston S, Reiter S, Werhya G, Reginster JY. Rizzoli R, et al. Among authors: devogelaer jp. Calcif Tissue Int. 2012 Oct;91(4):225-43. doi: 10.1007/s00223-012-9630-5. Epub 2012 Aug 10. Calcif Tissue Int. 2012. PMID: 22878667 Review.
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.
Compston J, Reid DM, Boisdron J, Brandi ML, Burlet N, Cahall D, Delmas PD, Dere W, Devogelaer JP, Fitzpatrick LA, Flamion B, Goel N, Korte S, Laslop A, Mitlak B, Ormarsdottir S, Ringe J, Rizzoli R, Tsouderos Y, Van Staa T, Reginster JY; Group for the Respect of Ethics and Excellence in Science. Compston J, et al. Among authors: devogelaer jp. Osteoporos Int. 2008 Sep;19(9):1247-50. doi: 10.1007/s00198-008-0670-7. Epub 2008 Jul 5. Osteoporos Int. 2008. PMID: 18604578 No abstract available.
Design for an ipriflavone multicenter European fracture study.
Reginster JY, Bufalino L, Christiansen C, Devogelaer JP, Gennari C, Riis BJ, Roux C. Reginster JY, et al. Among authors: devogelaer jp. Calcif Tissue Int. 1997;61 Suppl 1:S28-32. doi: 10.1007/s002239900382. Calcif Tissue Int. 1997. PMID: 9263614 Clinical Trial.
[Treatment of postmenopausal osteoporosis in 2004].
Reginster JY, Devogelaer JP. Reginster JY, et al. Among authors: devogelaer jp. Rev Med Liege. 2004 Nov;59(11):633-47. Rev Med Liege. 2004. PMID: 15646737 Free article. Review. French.
[Postmenopausal osteoporosis in women].
Reginster JY, Devogelaer JP, Kaufman JM, Appelboom T, Vanhaelst L. Reginster JY, et al. Among authors: devogelaer jp. Rev Med Liege. 1999 Apr;54(4):335-40. Rev Med Liege. 1999. PMID: 10389480 Free article. French.
270 results